By Angela McDaniels
Tacoma, Wash., Nov. 18 - NicOx SA sold €30.49 million of shares in a private placement, according to a company news release.
The company sold 4,065,688 shares for €7.50 each, which is a 7.4% discount to the company's share price on Tuesday.
Fonds Stratégique d'Investissement purchased €20 million of the shares, giving it a 5.1% stake in the company. FSI is owned 49% by the French government and is tasked with supporting medium-sized companies that are considered important for the growth and competitive position of the French economy.
Proceeds will be used to fund international research and development programs and for general corporate purposes.
NicOx is a pharmaceutical company based in Sophia Antipolis, France.
| Issuer: | NicOx SA
|
| Issue: | Shares
|
| Amount: | €30,491,000
|
| Shares: | 4,065,468
|
| Price: | €7.50
|
| Warrants: | No
|
| Investor: | Fonds Stratégique d'Investissement (for €20 million)
|
| Settlement date: | Nov. 18
|
| Stock symbol: | Euronext Paris: COX
|
| Stock price: | €8.10 at close on Nov. 17
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
